|
FAM13A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.025100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.040400E-04 |
| Normal-vs-Stage2 |
6.158100E-04 |
| Normal-vs-Stage3 |
1.64219999999604E-05 |
| Normal-vs-Stage4 |
1.901420E-01 |
| Stage1-vs-Stage2 |
6.859200E-01 |
| Stage1-vs-Stage3 |
1.986630E-01 |
| Stage1-vs-Stage4 |
3.481200E-01 |
| Stage2-vs-Stage3 |
3.700600E-01 |
| Stage2-vs-Stage4 |
2.135400E-01 |
| Stage3-vs-Stage4 |
6.247700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.166000E-04 |
| Normal-vs-AfricanAmerican |
1.824670E-03 |
| Normal-vs-Asian |
6.193900E-02 |
| Caucasian-vs-AfricanAmerican |
9.928600E-01 |
| Caucasian-vs-Asian |
8.476000E-01 |
| AfricanAmerican-vs-Asian |
8.633000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.033440E-04 |
| Normal-vs-Female |
5.769400E-04 |
| Male-vs-Female |
9.440800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.255700E-03 |
| Normal-vs-Extreme_Weight |
1.440250E-03 |
| Normal-vs-Obese |
3.75300000000633E-05 |
| Normal-vs-Extreme_Obese |
4.961900E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.627200E-01 |
| Normal_Weight-vs-Obese |
5.145200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.434400E-01 |
| Extreme_Weight-vs-Obese |
5.181000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.529200E-01 |
| Obese-vs-Extreme_Obese |
8.666000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.322550E-03 |
| Normal-vs-Age(41-60Yrs) |
3.544900E-03 |
| Normal-vs-Age(61-80Yrs) |
4.47390000000158E-05 |
| Normal-vs-Age(81-100Yrs) |
9.547800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.519000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.606200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.493200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.440000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.403600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.355400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.379200E-04 |
| Normal-VS-Type2 PRCC |
8.90220000049347E-07 |
| Normal-VS-KIRP CIMP |
4.638400E-03 |
| Normal-VS-Unclassified PRCC |
1.722710E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.621390E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.457170E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.579000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.755600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.599360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.267400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.55199999998901E-06 |
| Normal-vs-N1 |
1.839780E-04 |
| Normal-vs-N2 |
9.807200E-01 |
| N0-vs-N1 |
5.592400E-01 |
| N0-vs-N2 |
4.352200E-01 |
| N1-vs-N2 |
3.900200E-01 |
|
|
